Short‐term effects of quinapril and nifedipine on early renal changes in streptozotocin‐induced diabetes in rats

Fundamental & Clinical Pharmacology

Volumn 8, Issue 4, 1994, Pages 356-365

  Petitjean, P ^b   Vloemans, M ^a   Barthelmebs, M ^a   Stephan, D ^a   Grima, M ^a   Jund, A ^a   Imbs, JL ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

nifedipine; quinapril; rat; renal hemodynamic; streptozotocin induced diabetes

Indexed keywords

CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; NIFEDIPINE; QUINAPRIL; STREPTOZOCIN;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ELECTROLYTE EXCRETION; GLOMERULUS FILTRATION RATE; HYPERGLYCEMIA; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; CARBON DIOXIDE; COMPARATIVE STUDY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ISOQUINOLINES; KIDNEY; MALE; NIFEDIPINE; OXYGEN; PARTIAL PRESSURE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RENAL CIRCULATION; SUPPORT, NON-U.S. GOV'T;

EID: 0027981126     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1994.tb00813.x     Document Type: Article

References (42)

1. Garcia DL, Brenner FM. Short and long term effects of antihypertensive therapy in the diabetic rat
2. Nifedipine versus fosinopril in uninephrectomized diabetic rats
3. L‐Dopa and strep‐tozotocin‐induced diabetic nephropathy in rats
4. Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin‐induced diabetes in rats
5. A new coupling component for sulfanilamide determination
6. Long‐term enalapril and verapamil in rats with reduced renal mass
7. Kidney function and size in diabetics before and during initial insulin treatment
8. Measurement of urinary para‐aminohippuric acid in glycosuric diabetics
9. Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type I (insulin‐dependent) diabetic children
10. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms
11. Inhibition of angio‐tensin‐converting enzyme (ACE) in plasma and tissue
12. Induction of angiotensin I‐converting enzyme in rat lung with captopril (SQ 14225)
13. Dosage colorimétrique de l'inuline dans le sang et dans les urines. Application à l'analyse automatique
14. Évaluation de l'inhibition de l'enzyme de conversion par le rapport des concentrations plasmatiques d'angiotensine II et I
15. Effects of ACE‐inhibitors in hypertensive and normotensive patients with diabetic nephropathie
16. Glomerular hemodynamics in experimental diabetes mellitus
17. Reversal of renal cortical actions of angiotensin II by verapamil and manganese
18. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin‐induced diabetes in the rat
19. Relationships among altered glomerular barrier permse selectivity, angiotensin II and mesangial uptake on macro‐molecules
20. Biphasic alteration of renin‐angiotensin‐aldosterone system in streptozotocin‐diabetic rats
21. Prevention of hypertensive vascu‐lopathy by Nifedipine in salt‐loaded Dahl rats
22. Protein measurement with the phenol reagent
23. Renin‐angiotensin system beim diabetischen Patienten
24. Diuretic and natriuretic effects of nifedipine on isolated perfused rat kidneys
25. Effects of one‐hour and one‐week treatment with ramipril on plasma and renal brush border angiotensin converting enzyme in the rat
26. Increased kidney size and glomerular filtration rate in early juvenile diabetes
27. Predicting diabetic nephropathy in insulin‐dependent patients
28. Effects of converting‐enzyme inhibition on barrier function in diabetic glomerulopathy
29. Prolonged inhibition of local angiotensin‐converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats
30. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus
31. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy
32. Effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney
33. Increased glomerular filtration rate as a predictor of diabetic nephropathy ‐ an 8‐year prospective study
34. Streptozotocin (STZ)‐induced diabetes Mellitus in rats: effect of the ACE‐inhibitor quinapril on proteinuria
35. Renal actions of calcium antagonists
36. Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat
37. The effect of streptozotocin‐induced diabetes and insulin treatment on angiotensin converting enzyme activity
38. Quinapril: a review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders
39. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats
40. Assay of tissue angiotensin converting enzyme
41. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy
42. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension